Literature DB >> 23235992

A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges.

Evdokia Sourla1, Asimina Paspala, Afroditi Boutou, Paschalina Kontou, Ioannis Stanopoulos, Georgia Pitsiou.   

Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension (PH). Misdiagnosis of the disease is common since PVOD presents with clinical and radiographic features mimicking idiopathic pulmonary arterial hypertension or even PH due to interstitial lung disease. Vasodilators may not be efficacious in PVOD and may in fact worsen hemodynamic status with the development of pulmonary edema. Lung transplantation represents the best treatment option. In the present report we describe the challenging diagnosis of PVOD in a patient with PH referred to our department. Final diagnosis was established by surgical lung biopsy. The patient was offered sequential combination therapy under close monitoring and maintained remarkable clinical stabilization while being on the waiting list for lung transplantation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23235992     DOI: 10.1177/1753465812468042

Source DB:  PubMed          Journal:  Ther Adv Respir Dis        ISSN: 1753-4658            Impact factor:   4.031


  4 in total

1.  Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.

Authors:  Keith M Wille; Nirmal S Sharma; Tejaswini Kulkarni; Matthew R Lammi; Joseph B Barney; S Christopher Bellot; Ryan S Cantor; David C Naftel; Enrique Diaz-Guzman; David C McGiffin
Journal:  Ann Am Thorac Soc       Date:  2014-11

2.  Pulmonary hypertension secondary to pulmonary veno-occlusive disease complicated by right heart failure, hypotension and acute kidney injury.

Authors:  Nima Golzy; Stuti Fernandes; Justin Sharim; Rikin Tank; Henry D Tazelaar; Howard E Epstein; Victor Tapson; Antoine Hage
Journal:  Respir Med Case Rep       Date:  2016-09-27

3.  Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?

Authors:  Qin Luo; Qi Jin; Zhihui Zhao; Qing Zhao; Xue Yu; Lu Yan; Yi Zhang; Changming Xiong; Zhihong Liu
Journal:  BMC Pulm Med       Date:  2019-12-19       Impact factor: 3.317

4.  Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.

Authors:  Li Zhang; Yao Wang; Ruifeng Zhang
Journal:  Medicine (Baltimore)       Date:  2021-10-15       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.